Elevated CD3+ and CD8+ tumor-infiltrating immune cells correlate with prolonged survival in glioblastoma patients despite integrated immunosuppressive mechanisms in the tumor microenvironment and at the systemic level

被引:309
|
作者
Kmiecik, Justyna [1 ]
Poli, Aurelie [1 ]
Brons, Nicolaas H. C.
Waha, Andreas [2 ]
Eide, Geir Egil [3 ,4 ]
Enger, Per Oyvind [5 ]
Zimmer, Jacques
Chekenya, Martha [1 ,6 ]
机构
[1] Univ Bergen, Dept Biomed, N-5009 Bergen, Norway
[2] Univ Hosp, Dept Neuropathol, Bonn, Germany
[3] Haukeland Hosp, Clin Res Ctr, N-5021 Bergen, Norway
[4] Univ Bergen, Dept Global Publ Hlth & Primary Care, N-5020 Bergen, Norway
[5] Haukeland Hosp, Dept Neurosurg, N-5021 Bergen, Norway
[6] Univ Bergen, Dept Clin Dent, N-5009 Bergen, Norway
关键词
GBM; Tumor infiltrating cells; Regulatory T cells; Antigen presenting cells; REGULATORY T-CELLS; MGMT PROMOTER METHYLATION; NATURAL-KILLER-CELLS; NK CELLS; ADJUVANT TEMOZOLOMIDE; PROGNOSTIC VALUE; RECEPTOR; CANCER; EXPRESSION; NKG2D;
D O I
10.1016/j.jneuroim.2013.08.013
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We characterized GBM patients' tumor and systemic immune contexture with aim to reveal the mechanisms of immunological escape, their impact on patient outcome, and identify targets for immunotherapy. Increased CD3 T-cell infiltration was associated with prolonged survival independent of age, MGMT promoter methylation and post-operative treatment that implies potential for immunotherapy for GBM. Several mechanisms of escape were identified: within the tumor microenvironment: induced cD8+cD28 Foxp3 Tre that may tolerize antigen presenting cells, elevated CD73 and CD39 ectonucleotidases that suppress T-cell function, and at the systemic level: elevated IL-10 levels in serum, diminished helper T-cell counts, and upregulated inhibitory CTLA-4. (C) 2013 The Authors. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:71 / 83
页数:13
相关论文
共 50 条
  • [1] Density and location of CD3+ and CD8+ tumor-infiltrating lymphocytes correlate with prognosis of oral squamous cell carcinoma
    Zhou, Chen
    Wu, Yaping
    Jiang, Lei
    Li, Zhongwu
    Diao, Pengfei
    Wang, Dongmiao
    Zhang, Wei
    Liu, Laikui
    Wang, Yanling
    Jiang, Hongbing
    Cheng, Jie
    Yang, Jianrong
    JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2018, 47 (04) : 359 - 367
  • [2] The Prognostic Role of the Immune Microenvironment in Sinonasal Intestinal-Type Adenocarcinoma: A Computer-Assisted Image Analysis of CD3+ and CD8+ Tumor-Infiltrating Lymphocytes
    Ferrari, Marco
    Alessandrini, Lara
    Savietto, Enrico
    Cazzador, Diego
    Schiavo, Gloria
    Taboni, Stefano
    Carobbio, Andrea L. C.
    Calvanese, Leonardo
    Contro, Giacomo
    Gaudioso, Piergiorgio
    Emanuelli, Enzo
    Sbaraglia, Marta
    Zanoletti, Elisabetta
    Marioni, Gino
    Dei Tos, Angelo P.
    Nicolai, Piero
    JOURNAL OF PERSONALIZED MEDICINE, 2023, 13 (05):
  • [3] CD8+ tumor-infiltrating lymphocytes together with CD4+ tumor-infiltrating lymphocytes and dendritic cells improve the prognosis of patients with pancreatic adenocarcinoma
    Fukunaga, A
    Miyamoto, M
    Cho, Y
    Murakami, S
    Kawarada, Y
    Oshikiri, T
    Kato, K
    Kurokawa, T
    Suzuoki, M
    Nakakubo, Y
    Hiraoka, K
    Itoh, T
    Morikawa, T
    Okushiba, S
    Kondo, S
    Katoh, H
    PANCREAS, 2004, 28 (01) : E26 - E31
  • [4] Tumor-Infiltrating Lymphocytes (TILs) in Early Breast Cancer Patients: High CD3+, CD8+, and Immunoscore Are Associated with a Pathological Complete Response
    Rapoport, Bernardo Leon
    Nayler, Simon
    Mlecnik, Bernhard
    Smit, Teresa
    Heyman, Liezl
    Bouquet, Isabelle
    Martel, Marine
    Galon, Jerome
    Benn, Carol-Ann
    Anderson, Ronald
    CANCERS, 2022, 14 (10)
  • [5] The Abundance of Tumor-Infiltrating CD8+ Tissue Resident Memory T Lymphocytes Correlates with Patient Survival in Glioblastoma
    La Manna, Marco Pio
    Di Liberto, Diana
    Lo Pizzo, Marianna
    Mohammadnezhad, Leila
    Azgomi, Mojtaba Shekarkar
    Salamone, Vincenzo
    Cancila, Valeria
    Vacca, Davide
    Dieli, Costanza
    Maugeri, Rosario
    Brunasso, Lara
    Iacopino, Domenico Gerardo
    Dieli, Francesco
    Caccamo, Nadia
    BIOMEDICINES, 2022, 10 (10)
  • [6] Immune Checkpoint Inhibitor-induced Reinvigoration of Tumor-infiltrating CD8+ T Cells is Determined by Their Differentiation Status in Glioblastoma
    Park, Junsik
    Kwon, Minsuk
    Kim, Kyung Hwan
    Kim, Tae-Shin
    Hong, Seon-Hui
    Kim, Chang Gon
    Kang, Seok-Gu
    Moon, Ju Hyung
    Kim, Eui Hyun
    Park, Su-Hyung
    Chang, Jong Hee
    Shin, Eui-Cheol
    CLINICAL CANCER RESEARCH, 2019, 25 (08) : 2549 - 2559
  • [7] PD-L1, CD4+, and CD8+ Tumor-Infiltrating Lymphocytes (TILs) Expression Profiles in Melanoma Tumor Microenvironment Cells
    Caraban, Bogdan Marian
    Matei, Elena
    Cozaru, Georgeta Camelia
    Aschie, Mariana
    Deacu, Mariana
    Enciu, Manuela
    Baltatescu, Gabriela Izabela
    Chisoi, Anca
    Dobrin, Nicolae
    Petcu, Lucian
    Gheorghe, Emma
    Hangan, Laurentiu-Tony
    Rosu, Mihai Catalin
    Orasanu, Cristian Ionut
    Nicolau, Antonela-Anca
    JOURNAL OF PERSONALIZED MEDICINE, 2023, 13 (02):
  • [8] Prognostic relevance of sarcopenia and tumor-infiltrating CD8+ T cells in patients with hepatocellular carcinoma
    Doi, Shunsuke
    Yasuda, Satoshi
    Miyashita, Miu
    Nagai, Minako
    Nakamura, Kota
    Matsuo, Yasuko
    Terai, Taichi
    Kohara, Yuichiro
    Sakata, Takeshi
    Sho, Masayuki
    ANNALS OF GASTROENTEROLOGICAL SURGERY, 2024,
  • [9] Human breast tumor-infiltrating CD8+ T cells retain polyfunctionality despite PD-1 expression
    Egelston, Colt A.
    Avalos, Christian
    Tu, Travis Y.
    Simons, Diana L.
    Jimenez, Grecia
    Jung, Jae Y.
    Melstrom, Laleh
    Margolin, Kim
    Yim, John H.
    Kruper, Laura
    Mortimer, Joanne
    Lee, Peter P.
    NATURE COMMUNICATIONS, 2018, 9
  • [10] Human breast tumor-infiltrating CD8+ T cells retain polyfunctionality despite PD-1 expression
    Colt A. Egelston
    Christian Avalos
    Travis Y. Tu
    Diana L. Simons
    Grecia Jimenez
    Jae Y. Jung
    Laleh Melstrom
    Kim Margolin
    John H. Yim
    Laura Kruper
    Joanne Mortimer
    Peter P. Lee
    Nature Communications, 9